{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:13:53Z","timestamp":1790345633404,"version":"4.1.0"},"reference-count":124,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tainan Municipal Hospital (managed by Show Chwan Medical Care Corporation), Tainan, Taiwan","award":["RD-108007"],"award-info":[{"award-number":["RD-108007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Mumps is an important childhood infectious disease caused by mumps virus (MuV). We reviewed the epidemiology, pathogenesis, and vaccine development of mumps. Previous studies were identified using the key words \u201cmumps\u201d and \u201cepidemiology\u201d, \u201cpathogenesis\u201d or \u201cvaccine\u201d in MEDLINE, PubMed, Embase, Web of Science, and Google Scholar. We excluded the articles that were not published in the English language, manuscripts without abstracts, and opinion articles from the review. The number of cases caused by MuV decreased steeply after the introduction of the mumps vaccine worldwide. In recent years, a global resurgence of mumps cases in developed countries and cases of aseptic meningitis caused by some mumps vaccine strains have renewed the importance of MuV infection worldwide. The performance of mumps vaccination has become an important issue for controlling mumps infections. Vaccine development and routine vaccination are still effective measures to globally reduce the incidence of mumps infections. During outbreaks, a third of MMR vaccine is recommended for groups of persons determined by public authorities.<\/jats:p>","DOI":"10.3390\/ijerph17051686","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T07:33:46Z","timestamp":1583480026000},"page":"1686","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine"],"prefix":"10.3390","volume":"17","author":[{"given":"Shih-Bin","family":"Su","sequence":"first","affiliation":[{"name":"Department of Occupational Medicine, Chi-Mei Medical Center, Tainan 710, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Liang","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Surveillance, Centers for Disease Control, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kow-Tong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Occupational Medicine, Tainan Municipal Hospital (managed by Show Chwan Medical Care Corporation), Tainan 701, Taiwan"},{"name":"Department of Public Health, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(08)60419-5","article-title":"Mumps","volume":"371","author":"Hviid","year":"2008","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4149\/av_2013_02_91","article-title":"Overview of measles and mumps vaccine: Origin, present, and future of vaccine production","volume":"57","year":"2013","journal-title":"Acta Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/INF.0000000000001182","article-title":"Emerging mumps infection","volume":"35","author":"Rubin","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2165\/00003495-200363190-00012","article-title":"Measles, mumps, rubella vaccine (Priorix; GSK-MMR): A review of its use in the prevention of measles, mumps and rubella","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PHH.0000000000000962","article-title":"CDC guidance for use of a third dose of MMR vaccine during outbreaks","volume":"26","author":"Marlow","year":"2020","journal-title":"J. Public Health Manag. Pract."},{"key":"ref_6","first-page":"1","article-title":"Mumps surveillance\u2014United States, 1988\u20131993","volume":"44","author":"Holmes","year":"1995","journal-title":"MMWR CDC Surveill. Summ."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lewnard, J.A., and Grad, Y.H. (2018). Vaccine waning and mumps re-emergence in the United States. Sci. Transl. Med.","DOI":"10.1101\/185454"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S0022172400063385","article-title":"Epidemiology of mumps in The Netherlands","volume":"85","author":"Wagenvoort","year":"1980","journal-title":"J. Hyg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S0950268800066875","article-title":"The epidemiology of mumps in the UK: A preliminary study of virus transmission, herd immunity and the potential impact of immunization","volume":"99","author":"Anderson","year":"1987","journal-title":"Epidemiol. Infect."},{"key":"ref_10","first-page":"R21","article-title":"Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule","volume":"7","author":"Gay","year":"1997","journal-title":"Commun. Dis. Rep. CDR Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199411243312101","article-title":"The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program","volume":"331","author":"Peltola","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1001\/jama.284.20.2643","article-title":"Mumps and rubella eliminated from Finland","volume":"284","author":"Peltola","year":"2000","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/oxfordjournals.aje.a115395","article-title":"The epidemiology of mumps in southern Alberta, 1980\u20131982","volume":"130","author":"Falk","year":"1989","journal-title":"Am. J. Epidemiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1016\/j.vaccine.2012.09.070","article-title":"Mumps: Burden of disease in France","volume":"30","author":"Turbelin","year":"2012","journal-title":"Vaccine"},{"key":"ref_15","first-page":"88","article-title":"Mumps incidence in Israel\u2014Impact of MMR vaccine","volume":"18","author":"Slater","year":"1990","journal-title":"Public Health Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3855\/jidc.7560","article-title":"Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program","volume":"10","author":"Ngaovithunvong","year":"2016","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Cui, A., Zhu, Z., Hu, Y., Deng, X., Sun, Z., Zhang, Y., Mao, N., Xu, S., Fang, X., and Gao, H. (2017). Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013\u20132015. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169561"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3947\/ic.2015.47.1.1","article-title":"Resurgence of mumps in Korea","volume":"47","author":"Park","year":"2015","journal-title":"Infect. Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5694\/j.1326-5377.2008.tb02115.x","article-title":"Recent increases in mumps incidence in Australia: The \u201cforgotten\u201d age group in the 1998 Australian Measles Control Campaign","volume":"189","author":"Aratchige","year":"2008","journal-title":"Med. J. Aust."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12519-014-0525-6","article-title":"Epidemiologic features of mumps in Taiwan from 2006 to 2011: A new challenge for public health policy","volume":"11","author":"Chen","year":"2015","journal-title":"World J. Pediatr."},{"key":"ref_21","first-page":"3","article-title":"Mumps and mumps vaccine: A global review","volume":"77","author":"Galazka","year":"1999","journal-title":"Bull. World Health Organ."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ije\/29.2.362","article-title":"Ten years of serological surveillance in England and Wales: Methods, results, implications and action","volume":"29","author":"Osborne","year":"2000","journal-title":"Int. J. Epidemiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S0950268800004672","article-title":"European Sero-epidemiology Network. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: Implications for modelling studies","volume":"125","author":"Edmunds","year":"2000","journal-title":"Epidemiol. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.vaccine.2018.03.021","article-title":"A Phase III, open-label, randomized multicenter study to evaluate the immunogeneicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4 year-old healthy children in the UK","volume":"36","author":"Marlow","year":"2018","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/07420520600920718","article-title":"Seasonality of primarily childhood and young adult infectious diseases in the United States","volume":"23","author":"Shah","year":"2006","journal-title":"Chronobiol. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1461-0248.2005.00879.x","article-title":"Seasonality and the dynamics of infectious diseases","volume":"9","author":"Altizer","year":"2006","journal-title":"Ecol. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/archpedi.1970.02100070078008","article-title":"Mumps in a general population. A sero-epidemiologic study","volume":"120","author":"Levitt","year":"1970","journal-title":"Am. J. Dis. Child."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268812001136","article-title":"Seroepidemiology of mumps in Europe (1996\u20132008): Why do outbreaks occur in highly vaccinated populations?","volume":"141","author":"Eriksen","year":"2013","journal-title":"Epidemiol. Infect."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"B\u00e9raud, G., Abrams, S., Beutels, P., Dervaux, B., and Hens, N. (2018). Resurgence risk for measles, mumps and rubella in France in 2018 and 2020. Eurosurveillance, 23.","DOI":"10.2807\/1560-7917.ES.2018.23.25.1700796"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.it.2015.10.004","article-title":"Understanding Herd Immunity","volume":"36","author":"Metcalf","year":"2015","journal-title":"Trends Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/605410","article-title":"Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"200","author":"LeBaron","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1128\/JCM.43.9.4847-4851.2005","article-title":"Mumps virus-specific antibody titers from pre-vaccine era sera: Comparison of the plaque reduction neutralization assay and enzyme immunoassays","volume":"43","author":"Mauldin","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1017\/S0950268806006340","article-title":"Interpreting serological surveys using mixture models: The seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century","volume":"134","author":"Vyse","year":"2006","journal-title":"Epidemiol. Infect."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1080\/21645515.2015.1029687","article-title":"The association between the incidence of mumps and meteorological parameters in Taiwan. Hum","volume":"11","author":"Ho","year":"2015","journal-title":"Vaccin. Immunother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.4161\/hv.29286","article-title":"The relationship between meteorological factors and mumps incidence in Guangzhou, China, 2005\u20132012","volume":"10","author":"Yang","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1017\/S0950268810002967","article-title":"Effect of weather variability on the incidence of mumps in children: A time-series analysis","volume":"139","author":"Onozuka","year":"2011","journal-title":"Epidemiol. Infect."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.publhealth.28.021406.144128","article-title":"Seasonality of infectious diseases","volume":"28","author":"Fisman","year":"2007","journal-title":"Annu. Rev. Public Health"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhu, H., Zhao, H., Ou, R., Xiang, H., Hu, L., Jing, D., Sharma, M., and Ye, M. (2019). Epidemiological Characteristics and Spatiotemporal Analysis of Mumps from 2004 to 2018 in Chongqing, China. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16173052"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.4445","article-title":"Molecular biology, pathogenesis and pathology of mumps virus","volume":"235","author":"Rubin","year":"2015","journal-title":"J. Pathol."},{"key":"ref_41","unstructured":"Centers for Disease Control (CDC) (1989). Mumps prevention. MMWR Morb. Mortal. Wkly. Rep., 38, 388\u2013392."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/520028","article-title":"Mumps outbreaks in Canada and the United States: Time for new thinking on mumps vaccines","volume":"45","author":"Peltola","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4161\/hv.7943","article-title":"Mumps outbreaks in highly vaccinated populations: What makes good even better?","volume":"5","author":"Vandermeulen","year":"2009","journal-title":"Hum. Vaccin."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2807\/ese.13.16.18842-en","article-title":"An increase in the number of mumps cases in the Czech Republic, 2005\u20132006","volume":"13","author":"Boxall","year":"2008","journal-title":"Eurosurveillance"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1016\/j.vaccine.2007.04.013","article-title":"Mumps outbreak in highly vaccinated school population: Assessment of secondary vaccine failure using IgG avidity measurements","volume":"25","author":"Park","year":"2007","journal-title":"Vaccine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1473-3099(18)30607-8","article-title":"Mumps in a highly vaccinated Marshallese community in Arkansas, USA: An outbreak report","volume":"19","author":"Fields","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Vygen, S., Fischer, A., Meurice, L., Mounchetrou, N.I., Gregoris, M., Ndiaye, B., Ghenassia, A., Poujol, I., Stahl, J.P., and Antona, D. (2016). Waning immunity against mumps in Vaccinated young adults, France 2013. Eurosurveillance, 21.","DOI":"10.2807\/1560-7917.ES.2016.21.10.30156"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.4161\/hv.29484","article-title":"Outbreak of mumps in a school setting, United Kingdom, 2013","volume":"10","author":"Aasheim","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1473-3099(18)30498-5","article-title":"A protracted mumps outbreak in Western Australia despite high vaccine coverage: A population-based surveillance study","volume":"19","author":"Westphal","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","article-title":"Recent resurgence of mumps in the United States","volume":"358","author":"Dayan","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_51","first-page":"E10","article-title":"Australian vaccine preventable disease epidemiological review series: Mumps 2008-2012","volume":"39","author":"Bag","year":"2015","journal-title":"Commun. Dis Intell. Q. Report."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/INF.0b013e3181d743df","article-title":"Mumps outbreak in the Republic of Moldova, 2007\u20132008","volume":"29","author":"Schwarz","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0264-410X(01)00435-2","article-title":"Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance","volume":"20","author":"Pebody","year":"2002","journal-title":"Vaccine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.vaccine.2009.02.001","article-title":"Effectiveness of Jeryl Lynn-containing vaccine in Spanish children","volume":"27","author":"Castilla","year":"2009","journal-title":"Vaccine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3201\/eid1301.060649","article-title":"Vaccine effectiveness estimates, 2004\u20132005 mumps outbreak, England","volume":"13","author":"Cohen","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1086\/591196","article-title":"Mumps outbreaks in vaccinated populations: Are available mumps vaccines effective enough to prevent outbreaks?","volume":"47","author":"Dayan","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/bmj.330.7500.1132","article-title":"Mumps and the UK epidemic 2005","volume":"330","author":"Gupta","year":"2005","journal-title":"BMJ"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/oxfordjournals.aje.a121343","article-title":"Isolation of mumps virus from children with acute lower respiratory tract disease","volume":"94","author":"Foy","year":"1971","journal-title":"Am J Epidemiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/rmv.1819","article-title":"Genomic diversity of mumps virus and global distribution of the 12 genotypes","volume":"25","author":"Jin","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s10156-012-0515-3","article-title":"Mumps Hoshino and Torii vaccine strains were distinguished from circulating wild strains","volume":"19","author":"Sawada","year":"2013","journal-title":"J. Infect. Chemorther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcv.2014.11.004","article-title":"Mumps outbreak and laboratory diagnosis","volume":"62","author":"Maillet","year":"2015","journal-title":"J. Clin. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-3476(68)80347-6","article-title":"Isolation of virus during the incubation period of mumps infection","volume":"72","author":"Ennis","year":"1968","journal-title":"J. Pediatr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12026","DOI":"10.1128\/JVI.02048-15","article-title":"Mumps Virus Is Released from the Apical Surface of Polarized Epithelial Cells, and the Release Is Facilitated by a Rab11-Mediated Transport System","volume":"89","author":"Katoh","year":"2015","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archinte.1958.00030010354002","article-title":"Viremia in human mumps virus infections","volume":"102","author":"Overman","year":"1958","journal-title":"Arch. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/oxfordjournals.aje.a112125","article-title":"The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae","volume":"101","author":"Cooney","year":"1975","journal-title":"Am. J. Epidemiol."},{"key":"ref_66","first-page":"1","article-title":"Vaccine-Preventable Diseases In Pediatric Patients: A Review Of Measles, Mumps, Rubella, And Varicella","volume":"13","author":"Levine","year":"2016","journal-title":"Pediatr. Emerg. Med. Pract."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jemermed.2017.08.037","article-title":"Mumps: An Emergency Medicine-Focused Update","volume":"54","author":"Bockelman","year":"2018","journal-title":"J. Emerg. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/tropej\/45.6.358","article-title":"Fatal mumps nephritis and myocarditis","volume":"45","author":"Yekeler","year":"1999","journal-title":"J. Trop. Pediatr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MD.0b013e3181d63191","article-title":"Mumps orchitis in the post-vaccine era (1967\u20132009): A single-center series of 67 patients and review of clinical outcome and trends","volume":"89","author":"Boronat","year":"2010","journal-title":"Medicine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1620\/tjem.111.229","article-title":"Virus excretion and antibody response in saliva in natural mumps","volume":"111","author":"Chiba","year":"1973","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/iai.35.1.25-31.1982","article-title":"Mumps virus replication in human lymphoid cell lines and in peripheral blood lymphocytes: Preference for T cells","volume":"35","author":"Fleischer","year":"1982","journal-title":"Infect. Immun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1016\/j.vaccine.2017.07.051","article-title":"MMR and MMRV vaccines","volume":"36","author":"Kowalzik","year":"2018","journal-title":"Vaccine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0264-410X(97)00174-6","article-title":"Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines","volume":"16","author":"Schwarzer","year":"1998","journal-title":"Vaccine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0264-410X(90)90090-9","article-title":"Measles-mumps vaccination in the FRG: An empirical analysis after 14 years of use. I. Efficacy and analysis of vaccine failures","volume":"8","author":"Fescharek","year":"1990","journal-title":"Vaccine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/01.inf.0000183746.92218.f9","article-title":"Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children","volume":"24","author":"Tischer","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa021134","article-title":"A population-based study of measles, mumps, and rubella vaccination and autism","volume":"347","author":"Madsen","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa1703309","article-title":"Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control","volume":"377","author":"Cardemil","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Giaquinto, C., Gabutti, G., Baldo, V., Villa, M., Tramontan, L., Raccanello, N., Russo, F., Poma, C., Scamarcia, A., and Cantarutti, L. (2018). Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3017-9"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3181\/00379727-123-31599","article-title":"Live attenuated mumps virus vaccine. 1. Vaccine development","volume":"123","author":"Buynak","year":"1966","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1016\/j.vaccine.2006.06.049","article-title":"Mumps vaccine virus strains and aseptic meningitis","volume":"24","author":"Bonnet","year":"2006","journal-title":"Vaccine"},{"key":"ref_81","first-page":"33","article-title":"Aseptic meningitis following mumps vaccine. A retrospective survey by the French Regional Pharmacovigilance centres and by Pasteur-M\u00e9rieux S\u00e9rums and Vaccines. Pharmacoepidemiol","volume":"5","author":"Autret","year":"1996","journal-title":"Drug Saf."},{"key":"ref_82","unstructured":"WHO Expert Committee on Biological Standardization (1994). Forty Third Report, World Health Organization."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/INF.0000000000001241","article-title":"Safety and Immunogenicity of M-M-RII (Combination Measles-Mumps-Rubella Vaccine) in Clinical Trials of Healthy Children Conducted Between 1988 and 2009","volume":"35","author":"Kuter","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/140349488801600301","article-title":"Two doses of MMR vaccine\u2014Sufficient to eradicate measles, mumps and rubella?","volume":"6","author":"Fahlgren","year":"1988","journal-title":"Scand. J. Soc. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0264-410X(97)88332-6","article-title":"Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two\u2014Dose immunization programme","volume":"16","author":"Broliden","year":"1998","journal-title":"Vaccine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0264-410X(95)00064-8","article-title":"Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination: A nine-year follow-up","volume":"13","author":"Davidkin","year":"1995","journal-title":"Vaccine"},{"key":"ref_87","first-page":"81","article-title":"Clinical evaluation of a new measles\u2013 mumps\u2013rubella combined live virus vaccine in the Dominican Republic","volume":"52","author":"Ehrenkranz","year":"1975","journal-title":"Bull. World Health Organ."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/infdis\/169.1.77","article-title":"Sustained transmission of mumps in a highly vaccinated population: Assessment of primary vaccine failure and waning vaccine\u2013induced immunity","volume":"169","author":"Briss","year":"1994","journal-title":"J. Infect. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/cid\/cix718","article-title":"Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign-Iowa, July 2015\u2013May 2016","volume":"66","author":"Shah","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJM196702022760502","article-title":"Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation","volume":"276","author":"Hilleman","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1201-9712(02)90162-1","article-title":"An outbreak of mumps in the metropolitan area of Walsall, UK","volume":"6","author":"Pugh","year":"2002","journal-title":"Int. J. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2017.09.024","article-title":"Emergent lineages of mumps virus suggest the need for a polyvalent vaccine","volume":"66","author":"May","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"ref_93","unstructured":"Centers for Disease Control and Prevention (CDC) (2006). Mumps outbreak at a summer camp\u2014New York, 2005. MMWR Morb. Mortal. Wkly. Rep., 55, 175\u2013177."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/j.vaccine.2010.02.107","article-title":"Mumps vaccine effectiveness in highly immunized populations","volume":"28","author":"Torner","year":"2010","journal-title":"Vaccine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00006454-199705000-00009","article-title":"Risk of hospitalization because of aseptic meningitis after measles\u2013mumps\u2013rubella vaccination in one- to two-year-old children: An analysis of the Vaccine Safety Datalink (VSD) Project","volume":"16","author":"Black","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/peds.2005-0092","article-title":"A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax","volume":"117","author":"Reisinger","year":"2006","journal-title":"Pediatrics"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e1721","DOI":"10.1097\/MD.0000000000001721","article-title":"Combination measles-mumps-rubella-varicella vaccine in healthy children: A Systematic Review and Meta-analysis of Immunogenicity and Safety","volume":"94","author":"Ma","year":"2015","journal-title":"Medicine"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.vaccine.2009.01.112","article-title":"Comparative analysis of the complete neucleotide sequences of measles, mumps, and rubella strain genomes comtained in Priorix-TetraTM and ProQuadTM live attenuated combined vaccines","volume":"27","author":"Tillieux","year":"2009","journal-title":"Vaccine"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/21645515.2019.1578591","article-title":"Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: A randomized phase I\/II clinical trial","volume":"15","author":"Nakayama","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_100","first-page":"283","article-title":"Experience with live rubella virus vaccine combined with live vaccines against measles and mumps","volume":"42","author":"Smorodintsev","year":"1970","journal-title":"Bull. World Health Organ."},{"key":"ref_101","first-page":"302","article-title":"Aseptic meningitis after vaccination against measles and mumps","volume":"8","author":"Cizman","year":"1989","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-1157(89)90031-0","article-title":"Mumps vaccine L-Zagreb, prepared in chick fibroblasts: I. production and field trials","volume":"17","author":"Beck","year":"1989","journal-title":"J. Biol. Stand."},{"key":"ref_103","first-page":"983","article-title":"Immunogenicity and reactogenicity of indigenously produced MMR vaccine","volume":"32","author":"Bhargava","year":"1995","journal-title":"Indian Pediatr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0140-6736(93)90684-9","article-title":"Aseptic meningitis after measles, mumps, and rubella vaccine","volume":"341","author":"Tesovic","year":"1993","journal-title":"Lancet"},{"key":"ref_105","first-page":"29","article-title":"Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells","volume":"65","author":"Hoskins","year":"1986","journal-title":"Dev. Biol. Stand."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1651-2227.1983.tb09660.x","article-title":"Evaluation in young children of the Urabe Am 9 strain of live attenuated mumps vaccine in comparison with the Jeryl Lynn strain","volume":"72","author":"Vesikari","year":"1983","journal-title":"Acta Paediatr. Scand."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jinf.2004.10.001","article-title":"Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population","volume":"51","author":"Ong","year":"2005","journal-title":"J. Infect."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2807\/esm.01.04.00160-en","article-title":"Mumps epidemic in Portugal despite high vaccine coverage\u2014Preliminary report","volume":"1","author":"Dias","year":"1996","journal-title":"Eurosurveillance"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1024698900332","article-title":"Swiss Sentinel Surveillance Network. Comparison of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 2000: A case-cohort study","volume":"18","author":"Richard","year":"2003","journal-title":"Eur. J. Epidemiol."},{"key":"ref_110","first-page":"155","article-title":"Immune response to measles, mumps and rubella vaccine at 9, 12 and 15 months of age","volume":"100","author":"Singh","year":"1994","journal-title":"Indian J. Med. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00006454-199007000-00002","article-title":"Effect of monovalent measles and trivalent measles\u2013mumps\u2013rubella vaccines at various ages and concurrent administration with hepatitis B vaccine","volume":"9","author":"Huang","year":"1990","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0264-410X(94)00086-3","article-title":"Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines","volume":"13","author":"Miller","year":"1995","journal-title":"Vaccine"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0264-410X(91)90223-S","article-title":"Nucleotide sequence analysis of Urab mumps vaccine strain that caused meningitis in vaccine recipients","volume":"9","author":"Brown","year":"1991","journal-title":"Vaccine"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/infdis\/174.3.619","article-title":"The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease","volume":"174","author":"Brown","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0264-410X(95)00098-L","article-title":"Measles, mumps, and rubella antibodies in children 5\u20136 years after immunization: Effect of vaccine type and age of vaccination","volume":"13","author":"Boulianne","year":"1995","journal-title":"Vaccine"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/oxfordjournals.aje.a010239","article-title":"Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: Implications for immunization programs","volume":"151","author":"Dourado","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/viro.2001.1009","article-title":"Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain","volume":"287","author":"Amexis","year":"2001","journal-title":"Virology"},{"key":"ref_118","first-page":"253","article-title":"Vaccine\u2013related mumps meningitis\u2014Canada","volume":"16","author":"Furesz","year":"1990","journal-title":"Can. Dis. Wkly. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0140-6736(93)91069-X","article-title":"Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-199103000-00008","article-title":"Aseptic meningitis as a complication of mumps vaccination","volume":"10","author":"Sugiura","year":"1991","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(95)92311-X","article-title":"Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan","volume":"346","author":"Ueda","year":"1995","journal-title":"Lancet"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/JVI.06125-11","article-title":"Recent mumps outbreaks in vaccinated populations: No evidence of immune escape","volume":"86","author":"Rubin","year":"2012","journal-title":"J. Virol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CVI.00660-12","article-title":"Comparison of the Sensitivity of Laboratory Diagnostic Methods from a Well-Characterized Outbreak of Mumps in New York City in 2009","volume":"20","author":"Rota","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/529141","article-title":"Mumps vaccine performance among university students during a mumps outbreak","volume":"46","author":"Cortese","year":"2008","journal-title":"Clin. Infect. Dis."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/17\/5\/1686\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:04:26Z","timestamp":1760173466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/17\/5\/1686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":124,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["ijerph17051686"],"URL":"https:\/\/doi.org\/10.3390\/ijerph17051686","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]}}}